- Home
- BAX vs ICLR Comparison
BAX vs ICLR Comparison
Compare BAX & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BAX
- ICLR
- Stock Information
- Founded
- BAX 1931
- ICLR 1990
- Country
- BAX United States
- ICLR Ireland
- Employees
- BAX N/A
- ICLR N/A
- Industry
- BAX Medical/Dental Instruments
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- Sector
- BAX Health Care
- ICLR Health Care
- Exchange
- BAX Nasdaq
- ICLR Nasdaq
- Market Cap
- BAX 9.2B
- ICLR 14.3B
- IPO Year
- BAX N/A
- ICLR 1998
- Fundamental
- Price
- BAX $18.65
- ICLR $166.24
- Analyst Decision
- BAX Hold
- ICLR Buy
- Analyst Count
- BAX 10
- ICLR 15
- Target Price
- BAX $27.00
- ICLR $211.36
- AVG Volume (30 Days)
- BAX 8.2M
- ICLR 988.5K
- Earning Date
- BAX 10-30-2025
- ICLR 10-22-2025
- Dividend Yield
- BAX 3.73%
- ICLR N/A
- EPS Growth
- BAX N/A
- ICLR N/A
- EPS
- BAX N/A
- ICLR 7.47
- Revenue
- BAX $11,023,000,000.00
- ICLR $8,102,602,000.00
- Revenue This Year
- BAX $5.72
- ICLR N/A
- Revenue Next Year
- BAX $2.52
- ICLR $0.89
- P/E Ratio
- BAX N/A
- ICLR $21.10
- Revenue Growth
- BAX 3.90
- ICLR N/A
- 52 Week Low
- BAX $17.47
- ICLR $125.10
- 52 Week High
- BAX $37.74
- ICLR $228.29
- Technical
- Relative Strength Index (RSI)
- BAX 32.57
- ICLR 44.03
- Support Level
- BAX $17.57
- ICLR $155.00
- Resistance Level
- BAX $18.16
- ICLR $167.87
- Average True Range (ATR)
- BAX 0.56
- ICLR 6.44
- MACD
- BAX -0.18
- ICLR -1.22
- Stochastic Oscillator
- BAX 20.41
- ICLR 37.99
About BAX Baxter International Inc.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.